Targeted Capacity Expansion: Medication Assisted Treatment – Prescription Drug and Opioid Addiction Program

MAT-PDOA supports programs that expand/enhance access to medication-assisted treatment services for people with opioid use disorders.

Administering Agency:

SAMHSA

Learn More
Key Details:

Funding Overview:

MAT-PDOA supports programs that expand/enhance access to medication-assisted treatment services for people with opioid use disorders.

Common Uses:

Provide medication-assisted treatment (MAT) using FDA-approved medications, conduct clinical assessments, check prescription drug monitoring program, conduct screenings and assessments, ensure that practitioners have Drug Addiction Treatment Act waivers, develop funding mechanisms for rural and resource-limited counties and municipalities, provide telehealth, provide peer support services, obtain technical assistance, and engage/screen/assess people who are incarcerated within four months of release and may benefit from MAT upon release.

Issue Area(s): Substance Use Disorder

Eligibility: CBO/Other, City, County, State, Tribal

Key Usage Options: Peer Supports, Prescription Medication, Research/Evaluation, Screening/Assessment, Staff Training

Funding Amount/Range: Up to $524,000

Allocation Frequency: Annual

Funding/Expending Period: 3 years

Funding Type: Competitive Grant

How to Obtain: Application Process

Match Requirement: No

Notes:

MAT may be provided to incarcerated individuals within four months of their release to the community.